
    
      The primary endpoint of the study is the profile of differences in transcript levels of
      age-associated genes such as those in the lamin-A, insulin like growth factor (IGF) and NFKB
      pathways as well as noncoding RNAs in topical agent-exposed arm skin versus placebo exposed
      arm skin in healthy volunteers. The secondary endpoints include (1) differences in skin
      wrinkling using a 4 point Likert scale for wrinkle severity between placebo and topical agent
      exposed arm skin after 4 weeks of usage; (2) the type and severity of adverse events, both
      systemic and skin localized after exposure to both topical agent and placebo vehicle cream.
    
  